The total healthcare cloud computing market size is forecast to be almost $35bn in 2022, growing at a Compound Annual Growth Rate (CAGR) of 21.7% between 2018 and 2022 according to GlobalData’s recent report, ‘Cloud Computing in Healthcare – Thematic Research’

Some migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are facing disappointment after NICE rejected it in draft guidance.

The cost-effectiveness watchdog says that it can’t recommend routine NHS use of Aimovig (erenumab) for people suffering at least four migraine episodes each month, even though it is only intended for use after three earlier oral treatments have failed.

A new study has cast light on why some women with endometriosis experience infertility, with scientists saying the finding could lead to new treatment options. 

South Korea and US teams say infertility could be linked to deficiency of a protein in womb.

For patients with aggressive kidney and skin cancers, an immune-boosting protein called interleukin-2 (IL-2) can be a lifesaver. But the dose at which it fights cancer can also produce life-threatening side effects. 

Now, scientists have used computer modeling to design a new protein from scratch that mimics IL-2’s immune-enhancing abilities, while avoiding its dangerous side effects. The protein has so far been tested only in animals, but it may soon enter human trials.

Eli Lilly has announced its intention to buy pioneering cancer treatment development company Loxo Oncology in a deal worth approximately $8bn.

The agreement will cost Lilly $235 per share in cash, in a bid to boost its oncology portfolio with drugs for patients with genomically defined cancers.